TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region, with the establishment of an operational base in Melbourne, Australia. This strategic move marks a significant milestone in TFS's commitment to providing comprehensive clinical r…
Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the "Sanyou Intelligent Innovative Biologics R&D Service Platform," representing a transformative advancement in biopharmaceutical research and development. Our platform encompasses ten meticulously designed systems aimed at optimi…
Novartis announced it broke ground for the expansion of its biopharmaceutical manufacturing plant in Singapore. The US$256 million investment will facilitate Novartis in deploying digital and automation solutions to enhance manufacturing productivity, improve operational efficiency, and upskill the workforce. The expa…
Kyowa Kirin has selected Lee County to build its first North American pharmaceutical manufacturing operation, creating 102 jobs, Governor Roy Cooper announced today. The company will invest $200 million to establish a biologics manufacturing Center of Excellence in Sanford. In October of 2023, the Governor met with K…
South Korea-based Samsung Biologics and Seoul National University (SNU) have signed a Memorandum of Understanding (MoU) to foster bio experts as part of industrial-academia collaboration. Under the MOU, Samsung Biologics and the School of Biological Sciences at SNU will establish a programme to nurture bio talent, a…
Merck, a leading science and technology company, will open a new, € 20 million distribution centre in Cajamar, São Paulo, Brazil to better serve its life science customers in the region. The new space has an area of 13,000 square meters twice as large as the former location in Cotia. According to Vinícius Andremarchi…
Thermo Fisher Scientific, the world leader in serving science, will significantly expand local operations in Indonesia with the opening of its first official office. The inauguration of the new facility in Jakarta is scheduled for April, signifying a key milestone as the company transitions from its current representa…
Pharmascience, the largest Canadian-owned pharmaceutical company, announced a major $120 million sterile injectable manufacturing facility expansion at its Candiac site. Following this important milestone, the company is now proud to announce the expansion of its contract development and manufacturing organization (CD…
Synthetic biology could underpin an industry worth up to $30 billion per year and create over 50,000 new jobs by 2040, according to a new report by Australia’s national science agency, Commonwealth Scientific and Industrial Research Organisation (CSIRO), and Main Sequence Ventures. The Synthetic Biology National Pro…
With investments of approximately one billion euros, Japan headquartered Daiichi Sankyo will expand its production and development site in Pfaffenhofen an der Ilm, north of Munich, into an international innovation centre. At least 350 new jobs will be created by 2030, including numerous positions for top internationa…
Page 37 of 57